World News: 13:00 GMT Wednesday 12th June 2019. [Neos Therapeutics, Inc. via Globe Newswire via SPi World News]
DALLAS and FORT WORTH, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms, today announced that Jerry McLaughlin, its Chief Executive Officer, will present a company overview at two upcoming conferences in June.
A live webcast of both presentations will be available on the Investor Relations page of the company’s website at . Following each presentation, a replay of the webcast will be available on Neos’ website for 30 days.
Richard I. EisenstadtChief Financial OfficerNeos Therapeutics(972) 408-1389
Sarah McCabe Investor Relations Stern Investor Relations, Inc. (212) 362-1200
Globe Newswire: 13:00 GMT Wednesday 12th June 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.